1. Home
  2. CCM vs RANI Comparison

CCM vs RANI Comparison

Compare CCM & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Concord Medical Services Holdings Limited

CCM

Concord Medical Services Holdings Limited

N/A

Current Price

$3.74

Market Cap

23.8M

Sector

Health Care

ML Signal

N/A

Logo Rani Therapeutics Holdings Inc.

RANI

Rani Therapeutics Holdings Inc.

HOLD

Current Price

$1.40

Market Cap

24.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCM
RANI
Founded
1997
2012
Country
China
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.8M
24.2M
IPO Year
2009
2021

Fundamental Metrics

Financial Performance
Metric
CCM
RANI
Price
$3.74
$1.40
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$8.67
AVG Volume (30 Days)
4.0K
5.3M
Earning Date
09-26-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$51,056,841.00
$1,200,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.60
$0.39
52 Week High
$10.77
$3.87

Technical Indicators

Market Signals
Indicator
CCM
RANI
Relative Strength Index (RSI) 33.78 41.74
Support Level $3.71 $1.52
Resistance Level $4.00 $1.68
Average True Range (ATR) 0.21 0.17
MACD -0.03 -0.09
Stochastic Oscillator 10.68 0.65

Price Performance

Historical Comparison
CCM
RANI

About CCM Concord Medical Services Holdings Limited

Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services.

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Share on Social Networks: